Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy

The CPS+EG scoring system was initially described in unselected early breast cancer (eBC) patients treated with neoadjuvant chemotherapy (NAC), leading to refined prognostic stratification, and thus helping to select patients for additional post-NAC treatments. It remains unknown whether the performance is the same in new biological breast cancer entities such as the HER2-low subtype.

Source: European Journal of Cancer - March 23, 2024 Category: Cancer & Oncology Authors: Nicolas Roussot, Guillaume Constantin, Isabelle Desmoulins, Anthony Bergeron, Laurent Arnould, Fran çoise Beltjens, Didier Mayeur, Courèche Kaderbhai, Audrey Hennequin, Clémentine Jankowski, Marie Martine Padeano, Hélène Costaz, Sarah Jacinto, Eloise Tags: Original Research Source Type: research